Anyang-si, South Korea

Kyung-Ik Lee


Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Incheon, KR (2002 - 2005)
  • Anyang-si, KR (2002 - 2006)

Company Filing History:


Years Active: 2002-2006

Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Innovations of Kyung-Ik Lee: A Trailblazer in Pharmaceutical Advancements**

Introduction

Kyung-Ik Lee is a prominent inventor based in Anyang-si, South Korea, recognized for his significant contributions to the pharmaceutical industry. With a portfolio consisting of four patents, he has played a vital role in advancing innovative solutions for cardiovascular treatments and other medical applications.

Latest Patents

Kyung-Ik Lee's latest inventive contributions include two noteworthy patents. The first patent details a **method for the selective preparation of 3-oxo-4-aza-5α-androstane compound**. This invention relates to an innovative process that serves as an intermediate for finasteride, achieved by heating 3-oxo-4-aza-5-androstene in a mixture of formic acid and an alkanediol, with the help of zinc. This method enhances the efficiency and effectiveness of synthetic procedures in pharmaceutical chemistry.

His second patent, **Amlodipine camsylate and method for preparing thereof**, presents a crystalline salt form of amlodipine suitable for pharmaceutical formulations. This invention utilizes low toxic camphor sulfonic acid to create a stable compound that meets the necessary pharmaceutical properties required for treating cardiovascular diseases.

Career Highlights

Kyung-Ik Lee is currently affiliated with Hanmi Pharm. Co., Ltd., where he continues to innovate and contribute to the development of pharmaceutical products. His role at Hanmi Pharm allows him to collaborate with other professionals in the field and engage in the advancement of new medicinal compounds.

Collaborations

Throughout his career, Kyung-Ik Lee has worked alongside esteemed colleagues, including Young-ho Moon and Gwan-Sun Lee. These collaborations have fostered a dynamic environment for innovation and have enriched the research efforts within their organization.

Conclusion

Kyung-Ik Lee's dedication to pharmaceutical innovation is evident through his patents and collaborative efforts. His work not only contributes to the advancement of medical science but also illustrates the importance of inventive thinking within the pharmaceutical industry. As he continues to push the boundaries of innovation, his impact on the field is poised to grow even further.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…